United States Radiopharmaceutical Industry 2017 Market Research Report

July 2017 | 124 pages | ID: U2B0AC55294EN
QYResearch

Abstracts

This report studies the Radiopharmaceuticals market status and outlook of United States and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in United States and major regions, and splits the Radiopharmaceuticals market by product type and applications.

In the last several years, United States market of Radiopharmaceuticals developed smoothly, with an average growth rate of 6.7%. In 2016, United States revenue of Radiopharmaceuticals is nearly 2100 million USD.

The major players in United States Radiopharmaceuticals market include

• Bayer
• Triad Isotopes
• Lantheus
• GE Healthcare
• Mallinckrodt
• Eli Lilly
• Bracco Imaging
• SIEMENS
• Navidea
• Nordion
• IBA Group
• Jubilant Pharma

Geographically, this report is segmented into several key Regions, with Sales, revenue, Market Share (%) and Growth Rate (%) of Radiopharmaceuticals in these regions, from 2012 to 2022 (forecast), covering

• Mid-Atlantic Region
• South Atlantic
• West South Central
• Pacific Region
• Other

On the basis of product, the Radiopharmaceuticals market is primarily split into

• SPECT Radioisotopes
• PET Radioisotopes
• Other Diagnostic Radioisotopes
• Therapeutic Radioisotopes

On the basis on the end applications, this report covers

• Oncology
• Cardiology
• Other

Contents

1 RADIOPHARMACEUTICAL OVERVIEW

1.1 Product Overview and Scope of Radiopharmaceutical
  1.1.1 Product Overview
  1.1.2 Specifications of Radiopharmaceuticals
1.2 Classification of Radiopharmaceutical by Product Category
1.3 Applications of Radiopharmaceuticals
  1.3.1 Oncology
  1.3.2 Cardiology
  1.3.3 Other
1.4 United States Radiopharmaceuticals Market by Regions (2012-2022)
  1.4.1 United States Radiopharmaceuticals Market Size and Growth (%) Comparison by Regions (2012-2022)
  1.4.2 Mid-Atlantic Region Radiopharmaceuticals Status and Prospect (2012-2022)
  1.4.3 South Atlantic Radiopharmaceuticals Status and Prospect (2012-2022)
  1.4.4 West South Central Radiopharmaceuticals Status and Prospect (2012-2022)
  1.4.5 Pacific Region Radiopharmaceuticals Status and Prospect (2012-2022)
1.5 United States Radiopharmaceuticals Market Size (2012-2022)
  1.5.1 United States Radiopharmaceuticals Revenue Status and Outlook (2012-2022)
  1.5.2 United States Radiopharmaceuticals Sales Status and Outlook (2012-2022)

2 UNITED STATES RADIOPHARMACEUTICALS MARKET COMPETITION BY MANUFACTURERS/BRAND

2.1 United States Radiopharmaceuticals Sales and Share by Manufacturers (2016-2017)
2.2 United States Radiopharmaceuticals Revenue and Share by Manufacturers (2016-2017)
2.3 United States Radiopharmaceuticals Average Price by Manufacturers (2016-2017)
2.4 Radiopharmaceuticals Market Competitive Situation and Trends
  2.4.1 Radiopharmaceuticals Market Concentration Rate
  2.4.2 Radiopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Manufacturers Radiopharmaceutical Headquarter & R&D

3 UNITED STATES RADIOPHARMACEUTICALS SALES, REVENUE BY REGIONS (2012-2017)

3.1 United States Radiopharmaceuticals Sales and Market Share by Regions (2012-2017)
3.2 United States Radiopharmaceuticals Revenue and Market Share by Regions (2012-2017)
3.3 United States Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
3.4 United States Cyclotrons Install Base Dedicated to the Production of Medical Radionuclides (2015-2016)
3.5 Mid-Atlantic Region Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
3.6 South Atlantic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
3.7 West South Central Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
3.8 Pacific Region Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

4 UNITED STATES RADIOPHARMACEUTICALS SALES, REVENUE, PRICE TREND BY TYPES

4.1 United States Radiopharmaceuticals Sales and Market Share by Types (2012-2017)
4.2 United States Radiopharmaceuticals Revenue and Market Share by Types (2012-2017)
4.3 United States Radiopharmaceuticals Price by Type (2012-2017)
4.4 United States Radiopharmaceuticals Sales Growth by Type (2012-2017)

5 UNITED STATES RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONS

5.1 United States Radiopharmaceuticals Sales and Market Share by Applications (2012-2017)
5.2 United States Radiopharmaceuticals Sales Growth Rate by Applications (2012-2017)

6 MAJOR MANUFACTURERS ANALYSIS OF RADIOPHARMACEUTICALS

6.1 Bayer
  6.1.1 Company Profile
  6.1.2 Product Information
  6.1.3 Sales, Price, Cost, Gross, and Revenue
6.2 Triad Isotopes
  6.2.1 Company Profile
  6.2.2 Product Information
  6.2.3 Sales, Price, Cost, Gross, and Revenue
6.3 Lantheus Medical Imaging
  6.3.1 Company Profile
  6.3.2 Product Information
  6.3.3 Sales, Price, Cost, Gross, and Revenue
6.4 GE Healthcare
  6.4.1 Company Profile
  6.4.2 Product Information
  6.4.3 Sales, Price, Cost, Gross, and Revenue
6.5 Mallinckrodt
  6.5.1 Company Profile
  6.5.2 Product Information
  6.5.3 Sales, Price, Cost, Gross, and Revenue
6.6 Eli Lilly
  6.6.1 Company Profile
  6.6.2 Product Information
  6.6.3 Sales, Price, Cost, Gross, and Revenue
6.7 Bracco Imaging
  6.7.1 Company Profile
  6.7.2 Product Information
  6.7.3 Sales, Price, Cost, Gross, and Revenue
6.8 SIEMENS
  6.8.1 Company Profile
  6.8.2 Product Information
  6.8.3 Sales, Price, Cost, Gross, and Revenue
6.9 Navidea
  6.9.1 Company Profile
  6.9.2 Product Information
  6.9.3 Sales, Price, Cost, Gross, and Revenue
6.10 Nordion
  6.10.1 Company Profile
  6.10.2 Product Information
  6.10.3 Sales, Price, Cost, Gross, and Revenue
6.11 IBA Group
  6.11.1 Company Profile
  6.11.2 Product Information
  6.11.3 Sales, Price, Cost, Gross, and Revenue
6.12 Jubilant Pharma
  6.12.1 Company Profile
  6.12.2 Product Information
  6.12.3 Sales, Price, Cost, Gross, and Revenue

7 RADIOPHARMACEUTICAL MANUFACTURING COST ANALYSIS

7.1 Radiopharmaceutical Key Raw Materials Analysis
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost Analysis of Radiopharmaceuticals
  7.2.3 Other Costs Analysis
  7.2.4 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Radiopharmaceutical
7.4 Equipment Suppliers Analysis of Radiopharmaceuticals

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Radiopharmaceutical Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
  10.2.1 Cancer Patients Analysis
  10.2.2 Cardiology Patients Analysis
10.3 Economic/Political Environmental Change

11 UNITED STATES RADIOPHARMACEUTICALS MARKET FORECAST (2017-2022)

11.1 United States Radiopharmaceuticals Sales, Revenue Forecast (2017-2022)
  11.1.1 United States Radiopharmaceuticals Sales and Growth Rate Forecast (2017-2022)
  11.1.2 United States Radiopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 United States Radiopharmaceuticals Price and Trend Forecast (2017-2022)
11.2 United States Radiopharmaceuticals Sales and Revenue Forecast by Regions (2017-2022)
  11.2.1 Mid-Atlantic Region Radiopharmaceuticals Sales and Revenue Forecast (2017-2022)
  11.2.2 South Atlantic Radiopharmaceuticals Sales and Revenue Forecast (2017-2022)
  11.2.3 West South Central Radiopharmaceuticals Sales and Revenue Forecast (2017-2022)
  11.2.4 Pacific Region Radiopharmaceuticals Sales and Revenue Forecast (2017-2022)
11.3 United States Radiopharmaceuticals Sales Forecast by Type (2017-2022)
11.4 United States Radiopharmaceuticals Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Radiopharmaceutical
Table Specifications of Radiopharmaceuticals
Table Specifications of Technetium-99m
Table Classification of Radiopharmaceuticals
Figure United States Production Market Share of Radiopharmaceuticals by Type in 2016
Table United States PET/PETCT Install Base (Unit) in 2016
Table United States PET/PETCT Install Base (Unit) in 2016
Table Application Fields of Radiopharmaceuticals Products
Figure 2016 United States Radiopharmaceuticals Major Applications Sales Share
Figure Oncology Examples
Figure Cardiology Examples
Figure Other Examples
Table United States Market Radiopharmaceuticals Revenue (M USD) Comparison by Regions 2012-2022
Figure Mid-Atlantic Region Radiopharmaceuticals Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure South Atlantic Radiopharmaceuticals Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure West South Central Radiopharmaceuticals Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Pacific Region Radiopharmaceuticals Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure United States Radiopharmaceuticals Revenue (M USD) Status and Outlook (2012-2022)
Figure United States Radiopharmaceuticals Sales (M Doses) Status and Outlook (2012-2022)
Table United States Radiopharmaceuticals Sales (M Doses) of Key Manufacturers (2016-2017)
Table United States Radiopharmaceuticals Sales Share (%) by Manufacturers (2016-2017)
Figure 2016 Radiopharmaceuticals Sales Share (%) by Manufacturers
Figure 2017 Radiopharmaceuticals Sales Share (%) by Manufacturers
Table United States Radiopharmaceuticals Revenue (M USD) by Manufacturers (2016-2017)
Table United States Radiopharmaceuticals Revenue Share (%) by Manufacturers (2016-2017)
Figure 2016 United States Radiopharmaceuticals Revenue Share (%) by Manufacturers
Figure 2017 United States Radiopharmaceuticals Revenue Share (%) by Manufacturers
Table United States Market Radiopharmaceuticals Average Price (USD/Doses) of Key Manufacturers (2016-2017)
Figure United States Market Radiopharmaceuticals Average Price (USD/Doses) of Key Manufacturers in 2016
Figure United States Market Radiopharmaceuticals Average Price (USD/Doses) of Key Manufacturers in 2017
Figure Radiopharmaceuticals Revenue Market Concentration Rate in 2016
Figure Radiopharmaceuticals Revenue Market Share (%) of Top 3 Manufacturers
Figure Radiopharmaceuticals Revenue Market Share (%) of Top 5 Manufacturers
Table Industry News List of Radiopharmaceuticals
Table Headquarter of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016
Table R&D Status/Revenue and Sales Region of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016
Table United States Radiopharmaceuticals Sales (M Doses) by Regions (2012-2017)
Table United States Radiopharmaceuticals Sales Market Share (%) by Regions (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Regions (2012-2017)
Figure 2016 United States Radiopharmaceuticals Sales Market Share (%) by Regions
Table United States Radiopharmaceuticals Revenue (M USD) by Regions (2012-2017)
Table United States Radiopharmaceuticals Revenue Market Share (%) by Regions (2012-2017)
Figure United States Radiopharmaceuticals Revenue Market Share by Regions (2012-2017)
Figure 2016 United States Radiopharmaceuticals Revenue Market Share by Regions
Table United States Radiopharmaceuticals Sales (M Doses), Revenue (M USD), Price (USD/Doses) and Gross Margin (%) (2012-2017)
Table United States Cyclotrons Install Base (Unit) Dedicated to the Production of Medical Radionuclides (2015-2016)
Table Mid-Atlantic Region Radiopharmaceuticals Sales (M Doses), Revenue (M USD), Price (USD/Doses) and Gross Margin (%) (2012-2017)
Table South Atlantic Radiopharmaceuticals Sales (M Doses), Revenue (M USD), Price (USD/Doses) and Gross Margin (%) (2012-2017)
Table West South Central Radiopharmaceuticals Sales (M Doses), Revenue (M USD), Price (USD/Doses) and Gross Margin (%) (2012-2017)
Table Pacific Region Radiopharmaceuticals Sales (M Doses), Revenue (M USD), Price (USD/Doses) and Gross Margin (%) (2012-2017)
Table United States Radiopharmaceuticals Sales (M Doses) by Types (2012-2017)
Table United States Radiopharmaceuticals Sales Share (%) by Types (2012-2017)
Figure Sales Market Share (%) of Radiopharmaceuticals by Types (2012-2017)
Figure 2016 Sales Market Share (%) of Radiopharmaceuticals by Types
Table United States Radiopharmaceuticals Revenue (M USD) by Types (2012-2017)
Table United States Radiopharmaceuticals Revenue Share (%) by Types (2012-2017)
Figure Revenue Share of Radiopharmaceuticals by Types (2012-2017)
Figure 2016 Revenue Market Share (%) of Radiopharmaceuticals by Types
Table United States Radiopharmaceuticals Price (USD/Doses) by Types (2012-2017)
Figure United States Radiopharmaceuticals Sales Growth (%) by Type (2012-2017)
Table United States Radiopharmaceuticals Sales (M Doses) by Applications (2012-2017)
Table United States Radiopharmaceuticals Sales Market Share (%) by Applications (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Applications (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Applications in 2016
Table United States Radiopharmaceuticals Sales Growth Rate (%) by Applications (2012-2017)
Figure United States Radiopharmaceuticals Sales Growth Rate (%) by Applications (2012-2017)
Table Bayer Company Profile
Figure Radiopharmaceuticals Product Picture of Bayer
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of Bayer (2016-2017)
Table Triad Isotopes Company Profile
Figure Radiopharmaceuticals Product Picture of Triad Isotopes
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of Triad Isotopes (2016-2017)
Table Lantheus Medical Imaging Company Profile
Figure Radiopharmaceuticals Product Picture of Lantheus Medical Imaging
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of Lantheus Medical Imaging (2016-2017)
Table GE Healthcare Company Profile
Figure Radiopharmaceuticals Product Picture of GE Healthcare
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of GE Healthcare (2016-2017)
Table Mallinckrodt Company Profile
Figure Radiopharmaceuticals Product Picture of Mallinckrodt
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of Mallinckrodt (2016-2017)
Table Eli Lilly Company Profile
Figure Radiopharmaceuticals Product Picture of Eli Lilly
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of Eli Lilly (2016-2017)
Table Bracco Imaging Company Profile
Figure Radiopharmaceuticals Product Picture of Bracco Imaging
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of Bracco Imaging (2016-2017)
Table SIEMENS Company Profile
Figure Radiopharmaceuticals Product Picture of SIEMENS
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of SIEMENS (2016-2017)
Table Navidea Company Profile
Figure Radiopharmaceuticals Product Picture of Navidea
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of Navidea (2016-2017)
Table Nordion Company Profile
Figure Radiopharmaceuticals Product Picture of Nordion
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of Nordion (2016-2017)
Table IBA Group Company Profile
Figure Radiopharmaceuticals Product Picture of IBA Group Healthcare
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of IBA Group (2016-2017)
Table Jubilant Pharma Company Profile
Table Radiopharmaceuticals Product Picture of Jubilant Pharma
Table Radiopharmaceuticals Sales (M Doses), Price (USD/Doses), Cost (USD/Doses), Gross (USD/Doses), Revenue (M USD), Revenue Market Share and Gross Margin of Jubilant Pharma (2016-2017)
Table Production Base and Market Concentration Rate of Raw Material
Table Manufacturing Cost Structure Analysis of Radiopharmaceuticals in 2016
Figure USA Labor Cost Analysis
Figure Cost of Employing a Factory Worker
Table Average Price of Electricity to Ultimate Customers 2007-2016
Figure Manufacturing Process Analysis of Radiopharmaceutical
Table Equipment Suppliers Analysis of Radiopharmaceuticals
Figure Radiopharmaceutical Industrial Chain Analysis
Table Major Buyers of Radiopharmaceutical
Figure Marketing Channels Status of Radiopharmaceuticals
Figure Setting Pricing Policy
Table Distributors/Traders List
Figure Cardinal Health Distribution Center in Different States of USA
Figure Cancer Incidence by Country in 2016
Figure Cancer Mortality by Country in 2016
Figure USA numbers of new cancer cases for 2016
Figure Men Ages 35-74 Death Rate of CVDs
Figure Women Ages 35-74 Death Rate of CVDs
Figure Global GDP Growth Rate for 2015
Figure USA GDP (Billion USD) Change 2006-2016
Figure USA GDP Annual Growth Rate 2012-2016
Figure USA Consumer Price Index (CPI) 2016-2017
Figure United States Radiopharmaceuticals Sales (M Doses) and Growth Rate (%) Forecast (2017-2022)
Figure United States Radiopharmaceuticals Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure United States Radiopharmaceuticals Price (USD/Doses) and Trend Forecast (2017-2022)
Table United States Radiopharmaceuticals Sales (M Doses) Forecast by Regions (2017-2022)
Figure United States Radiopharmaceuticals Sales Market Share Forecast by Regions (2017-2022)
Figure Mid-Atlantic Region Radiopharmaceuticals Sales (M Doses) and Growth Rate (%) Forecast (2017-2022)
Figure Mid-Atlantic Region Radiopharmaceuticals Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure South Atlantic Radiopharmaceuticals Sales (M Doses) and Growth Rate (%) Forecast (2017-2022)
Figure South Atlantic Radiopharmaceuticals Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure West South Central Radiopharmaceuticals Sales (M Doses) and Growth Rate (%) Forecast (2017-2022)
Figure West South Central Radiopharmaceuticals Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure Pacific Region Radiopharmaceuticals Sales (M Doses) and Growth Rate (%) Forecast (2017-2022)
Figure Pacific Region Radiopharmaceuticals Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Table United States Radiopharmaceuticals Sales (M USD) Forecast by Type (2017-2022)
Figure United States Radiopharmaceuticals Sales Market Share (%) Forecast by Type (2017-2022)
Table United States Radiopharmaceuticals Sales (M Doses) Forecast by Application (2017-2022)
Figure United States Radiopharmaceuticals Sales Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources